Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leukotrienes in asthma].

M Ruiz Fernández1, G Flores Sandoval, M Orea Solano

  • 1R-V de alergia e inmunología clínica, Hospital Regional Lic. Adolfo López Mateos, ISSSTE, México, DF.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|September 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Transfer factor as specific immunomodulator in the treatment of moderate-severe atopic dermatitis].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2006
Same author

[Safety and efficacy of specific sublingual immunotherapy in patients with asthma and allergy to Dermatophagoides pteronyssinus].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2006
Same author

[Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2002
Same author

[Cell surface markers in patients with allergic rhinitis versus Der p and Der f challenge].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2001
Same author

[Respiratory function tests in aspirin-induced asthma].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2001
Same author

[Skin tests with high and minor determinants in patients with doubtful allergy to penicillin].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2001
Same journal

[Importance of early detection and prevention of secondary immunodeficiency in children with HIV].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

Rethinking tuberculosis: Microbiological and immunological crossroads in the post-pandemic era.

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Symmetrical flexural and intertriginous rash related to corticosteroids].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Consensus of Mexican experts on long-term prophylaxis in patients with hereditary angioedema in Mexico].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Hypersensitivity to iodinated contrast media: Diagnostic and therapeutic strategies. Position Statement of the Drug Allergy Committee of the Mexican College of Clinical Immunology and Allergy].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Analysis of scientific production on asthma - COPD overlap syndrome].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
See all related articles

Leukotrienes play a key role in asthma. New modulators targeting leukotriene pathways show therapeutic potential for asthma treatment, offering a promising new role in managing this respiratory condition.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Immunology

Context:

  • Leukotrienes are inflammatory mediators implicated in the pathophysiology of asthma.
  • Understanding their synthesis and biological effects is crucial for developing targeted therapies.

Purpose:

  • To review the biochemical and pharmacological aspects of leukotriene synthesis and action.
  • To evaluate the clinical efficacy of novel leukotriene modulators in various asthma models.

Summary:

  • This review covers the enzymatic and cellular pathways involved in leukotriene production.
  • Cysteinyl-leukotrienes are highlighted for their significant role in asthma.
  • Three classes of new modulators—5-lipoxygenase inhibitors, 5-lipoxygenase-activating protein antagonists, and cysteinyl-leukotriene receptor antagonists—are discussed.

Related Experiment Videos

Impact:

  • The reviewed modulators have demonstrated effects in diverse asthma models, including allergen, exercise, and aspirin-induced asthma.
  • Clinical experience suggests these modulators hold a new therapeutic role in asthma management.
  • This research provides insights into novel therapeutic strategies for respiratory diseases like asthma.